Get In Touch

GABA receptors are a broadly expressed type of receptors in the central nervous system and are responsible for causing various neurological conditions. GABA receptors agonist drugs act on GABA receptors to produce similar effects as that of chemical GABA. The drugs have sedative, anxiolytic, anticonvulsant, and muscle relaxant effects. There are two distinct classes of GABA receptors: GABAA and GABAB. These two receptors differ in pharmacological and electrophysiological properties. The development of more specific agonists for these receptor types has resulted in the increased adoption of these products for the treatment of critical conditions such as epilepsy, Alzheimer’s disease, etc.. This is due to their enhanced effectiveness resulting from the selective action on the receptor type. 

Factors such as arise in the incidence of GABA-related disorders, increase in research and development activities in advanced therapy areas, strong pipeline of upcoming molecules, rise in health care spending, and a favorable reimbursement scenario are expected to boost the global GABA receptor agonist drugs market in the coming years. However, limitations of the drug discovery process and lack of awareness in some regions about available therapies are expected to restrain the market during the forecast period. 

The global GABA receptor agonist drugs market can be segmented based on product, indication, distribution channel, and region. Based on product, the GABA receptor agonist drugs market can be categorized into GABAA receptor agonists and GABAB receptor agonists. In terms of indication, the global GABA receptor agonist drugs market can be classified into attention deficit hyperactivity disorder (ADHD), psychiatric disorders & depression, Alzheimer’s disease, epilepsy & seizures, anxiety & sleep disorders, and obesity. An increase in the aging population and rise in the incidence of Alzheimer’s disease are expected to boost the market in the near future.  Based on distribution channel, the global GABA receptor agonist market can be categorized into hospital pharmacy, retail pharmacy, and e-commerce. The hospital pharmacy segment is anticipated to dominate the market owing to high preference given to the hospital pharmacies by patients for buying products.  

In terms of region, the global GABA receptor agonist drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America continues to be the most profitable for vendors operating in the GABA receptor agonist drugs market, owing to a rise in the prevalence of neurological diseases in the region, significant adoption of technologically advanced products, presence of a large number of manufacturers in the U.S., and high health care spending in the region. For instance, according to a report by the Alzheimer’s Association published in 2018, Alzheimer’s disease accounts for an estimated 60% to 80% of cases of dementia, and an estimated 5.7 million Americans are living with the disease in 2018. Out of them, 5.5 million are above 65 years of age. Thus, an increase in the geriatric population across all regions is expected to boost the GABA receptor agonist drugs market in the region during the forecast period. Europe is a prominent region of the GABA receptor agonist drugs market, owing to the presence of a large geriatric population, rise in the incidence of brain disorders associated with GABA, high health care awareness, and rise in new product launches in the region. Asia Pacific and Latin America are expected to be lucrative regions of the GABA receptor agonist drugs market, due to the expansion of economies of countries in these regions, rise in population, and increase in health care awareness among the people in the region. 

Key players operating in the GABA receptor agonist drugs market include AstraZeneca, Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Athena Drug Delivery Solutions Pvt. Ltd., Apotex Inc., and Targeted Medical Pharma.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Gaba Receptor Agonist Drugs Market

Pre Book